Arthritis Rheumatoid Arthritis What Does a Vectra Test Show? Blood Test Assesses Disease Activity in Rheumatoid Arthritis By Carol Eustice Updated on January 05, 2024 Medically reviewed by Stella Bard, MD Print Table of Contents View All Table of Contents Vectra Test Measurements Before the Test During the Test After the Test Interpreting Results The Vectra DA is a blood test that measures disease activity in people already diagnosed with rheumatoid arthritis (RA). It is NOT used to diagnose RA. In addition to tracking disease activity, Vectra DA may "predict flare and sustained remission in patients discontinuing treatment, as well as treatment response to biologic and non-biologic therapies," according to research presented at the 2016 annual meeting of EULAR (European League Against Rheumatism). This article discusses the purpose of Vectra DA, what to expect when getting tested, and how to interpret test results. Kubra Cavus / Getty Images What Does the Vectra Test Measure? Your healthcare provider may order a Vectra DA test for you: If you're taking DMARDs (disease-modifying anti-rheumatic drugs) or biologic drugs and your medications aren't working well enough To assess your future risk of joint damage To decide whether you should discontinue a medication Developed by Crescendo Bioscience, Vectra DA looks at multiple biomarkers in your blood to create a picture of RA disease activity. A biomarker is a molecule in the body that can be objectively measured and evaluated via a simple blood test. The Vectra DA test measures levels of 12 key proteins associated with RA and compiles them into a single score between one and 100. This test is particularly helpful if both the CRP and ESR are normal. If the CRP is elevated, the test typically gives a high result. What Are the 12 Biomarkers in the Vectra Test? Because the Vectra DA measures a dozen markers, instead of measuring just two inflammatory markers (ESR and CRP), it is more accurate. It provides an accurate, reproducible score and an objective measure of RA disease activity that quantifies inflammatory status. Vectra DA's 12 Biomarkers VCAM-1 Vascular cell adhesion molecule-1 Marker of interactions between cells, blood vessels, and connective tissue in the joint that can contribute to the build up of inflammatory cells EGF Epidermal growth factor Promotes cell growth and inflammation in joints affected by RA VEGF-A Vascular endothelial growth factor Contributes to blood vessel formation, fluid buildup, and bone erosion in inflamed joints IL-6 Interleukin 6 Drives inflammation, cartilage deterioration, and bone erosion associated with RA TNF-R1 Tumor necrosis factor receptor, type 1 A receptor for the molecule TNF-alpha, which drives joint inflammation and destruction MMP-1 Matrix matalloproteinase-1 or collagenase-1 Contributes to cartilage destruction in RA MMP-3 Matrix matalloproteinase-3 or stomelysin-1 Destroys components of cartilage YKL-40 -- Helps regulate tissue remodeling and destruction Leptin -- Contributes to inflammation, regulates bone remodeling Resistin -- Contributes to inflammation, controls bone remodeling SAA Serum amyloid Produced in response to inflammation CRP C-reactive protein Produced in response to inflammation Vectra DA is a useful tool for monitoring the effects of medication on RA progression. In one study, Vectra DA was used to monitor the body's response to different doses of medication, providing evidence of the drug's effectiveness. A study looked at the Vectra scores of people newly diagnosed with RA and the correlation to the progression of joint damage seen on X-rays one year later. Twenty-one percent of people who scored high at baseline had damage one year later, whereas 2.9% of of people with low and moderate scores showed damage. This is another example of how the Vectra DA can be an important tool in RA treatment. Before the Test Before getting the test, make sure your healthcare provider knows about all medications you're taking, any current infections, and any recent surgeries, as they may affect your results. Timing The blood draw for the Vectra DA test shouldn't take more than a few minutes. If you're going to a lab or other facility specifically for the test, it's wise to call ahead and check on wait times. Location Vectra DA testing is typically done at healthcare provider's offices and medical labs. Your practitioner's office can tell you where your test will be performed. What to Wear Blood will be drawn from your arm, so be sure to wear short sleeves or sleeves that can easily be rolled up well past your elbow. Food and Drink You shouldn't need to fast before a Vectra DA test. If your healthcare provider has ordered multiple tests to be done at the same time, you may be given instructions about limiting food and drink beforehand. Always follow the instructions given to you by your practitioner's office and/or testing facility. If you tend to get nauseous when your blood is drawn, you may want to eat bland food or stick to small meals earlier in the day. Staying hydrated can make a blood draw easier to perform, which can lead to less discomfort for you. What to Bring When you arrive for your test, make sure you have: Your insurance cardCash or card to pay any copays that may be requiredProper identification, such as a driver's license or state-issued ID cardAny written orders your healthcare provider may have given youThe name of the healthcare provider who ordered the testA water bottle to ensure that you're hydrated You may also want to have something to read or occupy your time in case of a long wait. How Much Does Vectra Cost? The Vectra DA test costs around $1,000, but there are options for reducing the amount you have to pay. Is Vectra Covered by Insurance? Check with your insurance company or program to see whether the Vectra DA test is covered and to what extent. Medicare and Medicaid fully cover two Vectra DA tests per year with no out-of-pocket expenses. Vectra DA is now owned by Labcorp. During the Test The procedure for a Vectra DA test is the same as for any blood test. Your blood may be drawn by a phlebotomist, a nurse, or another type of medical technician. Pre-Test Before the test, you'll likely be asked to verify your name, date of birth, and possibly other identifying information along with the name of the test you're getting. This is to help avoid errors. Let the person drawing your blood know if you have a bleeding disorder or a history of negative reactions so they can take measures to help you. Throughout the Test The person drawing your blood will have you roll up your sleeve if necessary. Then they'll tie an elastic band around your arm to get your veins plump with blood. You may be asked to clench or pump your fist. Once a suitable vein is identified, they'll clean the area with rubbing alcohol, insert the needle, and extract a tube of blood. Once enough blood is collected, they'll withdraw the needle and bandage the site to help prevent further bleeding. Post-Test Once the test is over, you're free to go. If you get dizzy or nauseous, let someone know. They may have you lie down until you feel better. After the Test Most people come through a blood draw with no ill effects. If you have soreness or swelling at the injection site, an over-the-counter pain reliever and/or an ice pack may help. If you have signs of infection at the injection site (worsening redness, soreness, swelling, or pain) or any other problems after the test, call your healthcare provider. Interpreting Results The facility where your blood was drawn will send the sample to the Crescendo Bioscience lab for analysis. The company says your healthcare provider will receive your results in about a week. You may be able to access your test result at VectraScore.com, and your healthcare provider may contact you with the results via phone, mail, email, or online patient portal. The test results will be in the form of a number between one and 100. Vectra DA Results 1-29 Low disease activity 30-44 Moderate disease activity 45-100 High disease activity What Does a Low Vectra Score Mean? A Vectra score between one and 29 indicates low disease activity. Typically those with persistent low Vectra scores are less likely to develop joint damage and less aggressive treatment may be indicated. What Does a Moderate Vectra Score Mean? A Vectra score between 30 and 44 indicates moderate disease activity and inflammation. People with persistently moderate disease activity are less likely to develop joint damage compared to people with high Vectra scores. Typically less aggressive treatment is needed. What Does a High Vectra Score Mean? A higher Vectra score (45 to 100) indicates more severe disease progression with early development of joint damage and more frequent flares. Higher Vectra scores have also been linked with stroke and heart attack in people with RA due to excessive inflammation in the body. Follow-Up Depending on your test results, your healthcare provider may want you to schedule an appointment to talk about changes in your medications, other treatment options, or your risk of future joint damage. If you have questions about your results or aren't contacted by your healthcare provider's office, give them a call. Summary The Vectra DA test can help you and your healthcare provider make treatment decisions and give you important information about the course of your rheumatoid arthritis. It's one of many tools you and your medical team have as you work together to control your disease and maintain your function and quality of life. Alternative Treatments for Rheumatoid Arthritis 5 Sources Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. Hirata S, Tang S, Hwang C, et al. FRI0096 Predictive Value of The Multi-Biomarker Disease Activity (MBDA) Score for Flare and Sustained Remission in The Honor Study. Annals of the Rheumatic Diseases. 2016;75:462. Segurado OG, Sasso EH. Vectra DA for the objective measurement of disease activity in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2014;32(5 Suppl 85):S-29-34. Karnell JL, Albulescu M, Drabic S, et al. A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunity. Sci Transl Med. 2019 Apr 24;11(489):eaar6584. doi: 10.1126/scitranslmed.aar6584 Hambardzumyan K, Bolce R, Saevarsdottir S, et al. Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial. Annals of the Rheumatic Diseases 2015;74:1102-1109. Liao KP. Cardiovascular disease in patients with rheumatoid arthritis. Trends Cardiovasc Med. 2017 Feb;27(2):136-140. doi: 10.1016/j.tcm.2016.07.006 By Carol Eustice Carol Eustice is a writer covering arthritis and chronic illness, who herself has been diagnosed with both rheumatoid arthritis and osteoarthritis. See Our Editorial Process Meet Our Medical Expert Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Accept All Cookies